| Dr Roberto Armando Celada, MD | |
|
501 S Shore Ctr W, Suite F, Alameda, CA 94501-5762 | |
| (510) 814-4630 | |
| (510) 814-4644 |
| Full Name | Dr Roberto Armando Celada |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 501 S Shore Ctr W, Alameda, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336302959 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | A90276 (California) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
A team of researchers from Cleveland Clinic and New York University School of Medicine have found that obesity resulted in as much as 47 percent more life-years lost than tobacco, and tobacco caused similar life-years lost as high blood pressure.
Bristol-Myers Squibb Company announced today that it has completed its previously announced acquisition of privately held Amira Pharmaceuticals, Inc., a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.
Cadient Group, the premier strategic interactive marketing agency serving the healthcare industry, today announced that it has been recognized as one of the fastest growing technology, life sciences and cleantech companies in the Greater Philadelphia region for the second consecutive year.
BioScrip, Inc. today announced 2010 fourth quarter and year-end financial results. Fourth quarter revenue was $450.4 million with a net loss of $67.1 million, or $1.25 per share, which included a deferred-tax asset valuation allowance expense of $54.0 million and $9.2 million of litigation, restructuring, integration, acquisition, severance and CAP bad debt expense.
Speaking at a national malaria forum in Nairobi on Monday, Charles Mbogo of the Kenya Medical Research Institute (KEMRI) presented new evidence showing that malaria-causing mosquitos in Kenya have developed resistance to the most common chemicals derived from pyrethroids and DDT, which "could be a major blow to the country's strategy to eradicate malaria by 2017," Nigeria's the Nation reports.
› Verified 1 days ago
| Entity Name | Alameda Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740332931 PECOS PAC ID: 3779494521 Enrollment ID: O20031110000764 |
News Archive
A team of researchers from Cleveland Clinic and New York University School of Medicine have found that obesity resulted in as much as 47 percent more life-years lost than tobacco, and tobacco caused similar life-years lost as high blood pressure.
Bristol-Myers Squibb Company announced today that it has completed its previously announced acquisition of privately held Amira Pharmaceuticals, Inc., a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.
Cadient Group, the premier strategic interactive marketing agency serving the healthcare industry, today announced that it has been recognized as one of the fastest growing technology, life sciences and cleantech companies in the Greater Philadelphia region for the second consecutive year.
BioScrip, Inc. today announced 2010 fourth quarter and year-end financial results. Fourth quarter revenue was $450.4 million with a net loss of $67.1 million, or $1.25 per share, which included a deferred-tax asset valuation allowance expense of $54.0 million and $9.2 million of litigation, restructuring, integration, acquisition, severance and CAP bad debt expense.
Speaking at a national malaria forum in Nairobi on Monday, Charles Mbogo of the Kenya Medical Research Institute (KEMRI) presented new evidence showing that malaria-causing mosquitos in Kenya have developed resistance to the most common chemicals derived from pyrethroids and DDT, which "could be a major blow to the country's strategy to eradicate malaria by 2017," Nigeria's the Nation reports.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roberto Armando Celada, MD 501 S Shore Ctr W, Suite 103f, Alameda, CA 94501-5762 Ph: (510) 814-4630 | Dr Roberto Armando Celada, MD 501 S Shore Ctr W, Suite F, Alameda, CA 94501-5762 Ph: (510) 814-4630 |
News Archive
A team of researchers from Cleveland Clinic and New York University School of Medicine have found that obesity resulted in as much as 47 percent more life-years lost than tobacco, and tobacco caused similar life-years lost as high blood pressure.
Bristol-Myers Squibb Company announced today that it has completed its previously announced acquisition of privately held Amira Pharmaceuticals, Inc., a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.
Cadient Group, the premier strategic interactive marketing agency serving the healthcare industry, today announced that it has been recognized as one of the fastest growing technology, life sciences and cleantech companies in the Greater Philadelphia region for the second consecutive year.
BioScrip, Inc. today announced 2010 fourth quarter and year-end financial results. Fourth quarter revenue was $450.4 million with a net loss of $67.1 million, or $1.25 per share, which included a deferred-tax asset valuation allowance expense of $54.0 million and $9.2 million of litigation, restructuring, integration, acquisition, severance and CAP bad debt expense.
Speaking at a national malaria forum in Nairobi on Monday, Charles Mbogo of the Kenya Medical Research Institute (KEMRI) presented new evidence showing that malaria-causing mosquitos in Kenya have developed resistance to the most common chemicals derived from pyrethroids and DDT, which "could be a major blow to the country's strategy to eradicate malaria by 2017," Nigeria's the Nation reports.
› Verified 1 days ago
Dr. Nolli Silva Riordan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1002 Central Ave, Alameda, CA 94501 Phone: 510-521-6078 Fax: 510-521-6079 | |
Dr. John Hochung Lee, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 815 Atlantic Ave, Alameda, CA 94501 Phone: 510-535-7363 Fax: 510-864-1483 | |
Pamela J Mcbride, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2111 Whitehall Pl, Ste B, Alameda, CA 94501 Phone: 510-521-2027 Fax: 510-521-2029 |